Well Lead Med Co Ltd (603309) — Capital Reinvestment Ratio
Well Lead Med Co Ltd (603309) has a Capital Reinvestment Ratio of 0.49x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥126.26 Million) in capital expenditures (CN¥62.08 Million). See Well Lead Med Co Ltd (603309) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Well Lead Med Co Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Well Lead Med Co Ltd's Capital Reinvestment Ratio across 14 annual periods. Check 603309 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Well Lead Med Co Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Well Lead Med Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see market cap of Well Lead Med Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.03x | CN¥306.26 Million | CN¥315.73 Million | ▼ -32.7% |
| 2023 | 1.53x | CN¥233.51 Million | CN¥357.89 Million | ▲ +230.5% |
| 2022 | 0.46x | CN¥391.13 Million | CN¥181.38 Million | ▼ -20.5% |
| 2021 | 0.58x | CN¥187.28 Million | CN¥109.28 Million | ▲ +44.1% |
| 2020 | 0.40x | CN¥228.44 Million | CN¥92.49 Million | ▼ -35.7% |
| 2019 | 0.63x | CN¥178.79 Million | CN¥112.54 Million | ▼ -28.1% |
| 2018 | 0.88x | CN¥89.89 Million | CN¥78.66 Million | ▼ -8.5% |
| 2017 | 0.96x | CN¥74.34 Million | CN¥71.12 Million | ▲ +18.4% |
| 2016 | 0.81x | CN¥85.35 Million | CN¥68.93 Million | ▲ +77.9% |
| 2015 | 0.45x | CN¥81.47 Million | CN¥36.98 Million | ▼ -5.4% |
| 2014 | 0.48x | CN¥107.34 Million | CN¥51.49 Million | ▼ -18.9% |
| 2013 | 0.59x | CN¥72.85 Million | CN¥43.06 Million | ▲ +4.9% |
| 2012 | 0.56x | CN¥83.23 Million | CN¥46.92 Million | ▼ -44.5% |
| 2011 | 1.02x | CN¥44.08 Million | CN¥44.77 Million | — |